Professor Dr. Julio Aguirre-Ghiso is the Director of Head and Neck Cancer Basis Research and Solid Tumor and Metastasis Research. His research group is part of the Division of Hematology and Oncology, Department of Medicine in Mount Sinai. Professor Aguirre-Ghiso has made outstanding contributions in unraveling the Biology of Residual Disease.

• Preface.- Foreword. Understanding and targeting minimal residual disease: a path to change cancer patient outcomes.- Epigenetics and Pluripotency Aspects of Disseminated Cancer Cells during Minimal Residual Disease.- Anti-angiogenic therapy-mediated endothelial damage: A driver of breast cancer recurrence?- Minimal Residual Disease in Prostate Cancer.- Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer.- Detection of Minimal Residual Disease and its Clinical Applications in Melanoma and Breast Cancer Patients Selena.- Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.-Minimal Residual Disease in Acute Myeloid leukemia.- Characteristics and therapeutic targeting of minimal residual disease in childhood acute lymphoblastic leukemia.- Minimal Residual Disease in Multiple Myeloma: Impact on response assessment, prognosis and tumor heterogeneity.- Index.

Professor Dr. Julio Aguirre-Ghiso is the Director of Head and Neck Cancer Basis Research and Solid Tumor and Metastasis Research. His research group is part of the Division of Hematology and Oncology, Department of Medicine in Mount Sinai. Professor Aguirre-Ghiso has made outstanding contributions in unraveling the Biology of Residual Disease.

• Preface.- Foreword. Understanding and targeting minimal residual disease: a path to change cancer patient outcomes.- Epigenetics and Pluripotency Aspects of Disseminated Cancer Cells during Minimal Residual Disease.- Anti-angiogenic therapy-mediated endothelial damage: A driver of breast cancer recurrence?- Minimal Residual Disease in Prostate Cancer.- Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer.- Detection of Minimal Residual Disease and its Clinical Applications in Melanoma and Breast Cancer Patients Selena.- Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.-Minimal Residual Disease in Acute Myeloid leukemia.- Characteristics and therapeutic targeting of minimal residual disease in childhood acute lymphoblastic leukemia.- Minimal Residual Disease in Multiple Myeloma: Impact on response assessment, prognosis and tumor heterogeneity.- Index.

Professor Dr. Julio Aguirre-Ghiso is the Director of Head and Neck Cancer Basis Research and Solid Tumor and Metastasis Research. His research group is part of the Division of Hematology and Oncology, Department of Medicine in Mount Sinai. Professor Aguirre-Ghiso has made outstanding contributions in unraveling the Biology of Residual Disease.

• Preface.- Foreword. Understanding and targeting minimal residual disease: a path to change cancer patient outcomes.- Epigenetics and Pluripotency Aspects of Disseminated Cancer Cells during Minimal Residual Disease.- Anti-angiogenic therapy-mediated endothelial damage: A driver of breast cancer recurrence?- Minimal Residual Disease in Prostate Cancer.- Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer.- Detection of Minimal Residual Disease and its Clinical Applications in Melanoma and Breast Cancer Patients Selena.- Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.-Minimal Residual Disease in Acute Myeloid leukemia.- Characteristics and therapeutic targeting of minimal residual disease in childhood acute lymphoblastic leukemia.- Minimal Residual Disease in Multiple Myeloma: Impact on response assessment, prognosis and tumor heterogeneity.- Index.